phenoxyethyl alcohol
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
1
Earliest trial started Oct 1, 2011 (NCT01434914)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Approved for
Mechanism of action
GRIN2A inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
OCCOc1ccccc1- Mol. weight
- 138.17 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1229846 ↗
Also known as
- (2-hydroxyethoxy)benzene
- 2-phenoxyethanol
- 2-phenoxyethanol
- 2-phenoxyethanol
- 2-phenoxyethanol
- 2-phenoxyethanol
- emuclens
- erisept
- ethylene glycol monophenyl ether
- ethylene glycol monophenyl ether
- phenoxethol
- phenoxethol
- phenoxyethanol
- phenoxyethanol
- phenoxyethanol
- phenoxyethanol
- phenoxyethanol
- phenoxyethanol
- phenoxyethanol
- phenoxyethyl alcohol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02943486 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2017 | Universidad Autónoma de Bucaramanga |
| NCT01434914 | Phase 4 | Oct 1, 2011 | Schülke & Mayr GmbH, University of Hamburg |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Schülke & Mayr GmbH | For profit | 1 | 1 | 1 | 2011 |
| Universidad Autónoma de Bucaramanga | Academic/Hospital | 1 | 1 | 1 | 2017 |
| University of Hamburg | Academic/Hospital | 1 | 0 | 1 | 2011 |
3 organizations
Page 1 / 1